Home ›
Organizations ›
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
CA · Healthcare · EIN 473355381
34
Executives Disclosed
$66.9M
Annual Revenue
$223.9M
Total Assets
1.9:1
Internal Pay Ratio
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY has 34 executives with disclosed compensation. The highest-paid executive, Jeffrey A Bluestone (PRESIDENT/CEO & DIRECTOR), received peak total compensation of $917,060. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Jeffrey A Bluestone | PRESIDENT/CEO & DIRECTOR | $917K | $733K | 2016–2019 | 12.2x |
| Ramy Ibrahim | DIRECTOR & FORMER CMO | $910K | $539K | 2016–2021 | 12.1x |
| Ute Dugan | CHIEF MEDICAL OFFICER | $844K | $844K | 2021–2023 | 11.3x |
| John Connolly | CHIEF SCIENTIFIC OFFICER | $818K | $818K | 2020–2023 | 10.9x |
| Kevin Marks | CHIEF LEGAL OFFICER | $674K | $674K | 2023–2023 | 9x |
| Tarak Mody | CHIEF BUSINESS OFFICER | $670K | $670K | 2023–2023 | 8.9x |
| Theresa Lavalle | VP TRANSLATIONAL MEDICINE & RE | $610K | $610K | 2021–2021 | 8.1x |
| Adam M Kolom | VP-Business Development | $610K | $610K | 2016–2016 | 8.1x |
| Shane Corcoran | SENIOR VP, STRAT. OPS. & COMMS | $589K | $589K | 2023–2023 | 7.8x |
| Sara Coblin | SR VP FINANCE & ADMIN. | $587K | $587K | 2021–2023 | 7.8x |
| Melinda Griffith | CHIEF LEGAL COUNSEL | $543K | $543K | 2016–2021 | 7.2x |
| Frederic Pla | COO THROUGH 4/15/21 | $534K | $386K | 2020–2021 | 7.1x |
| Ilan Zipkin | VP-BUSINESS DEVELOPMENT | $511K | $511K | 2017–2018 | 6.8x |
| Marko Spasic | SR MEDICAL DIR, HEAD OF MED | $491K | $491K | 2021–2023 | 6.6x |
| Theresa Lavallee | VP-TRANSLATIONAL MEDICINE | $489K | $489K | 2017–2020 | 6.5x |
| Frederick J Ramsdell | CHIEF SCIENTIFIC OFFICER (THRU 12/19) | $458K | $458K | 2019–2019 | 6.1x |
| Susan Schultz Thru 9120 | VP-BUSINESS OPERATIONS | $452K | $452K | 2020–2020 | 6x |
| Lisa Butterfield | VP RESEARCH & DEVELOPMENT | $451K | $451K | 2020–2021 | 6x |
| Nikesh Kotecha | VP-INFORMATICS | $449K | $449K | 2016–2020 | 6x |
| Justin Fairchild | VP CLINICAL DEVELOPMENT | $442K | $442K | 2021–2021 | 5.9x |
| Cheryl Selinsky | VP-RESEARCH OPERATIONS | $411K | $411K | 2019–2020 | 5.5x |
| Susan Schultz | VP-BUSINESS OPERATIONS | $410K | $410K | 2016–2019 | 5.5x |
| Cheryl L Selinsky | VP-RESEARCH OPERATIONS | $402K | $386K | 2016–2018 | 5.4x |
| Chris Cabanski | SR DIR, NETWORK CLINICAL RES. | $397K | $397K | 2023–2023 | 5.3x |
| Jennifer Haslip | VP-COMMUNICATIONS | $352K | $352K | 2016–2017 | 4.7x |
| Fred Ramsdell | VP-RESEARCH | $332K | $332K | 2016–2017 | 4.4x |
| David Hoffman | EXECUTIVE DIRECTOR-INTELLE | $331K | $331K | 2016–2017 | 4.4x |
| Stephanie Liva | SR DIRECTOR-INTELLECTUAL PROPERTY | $285K | $285K | 2017–2017 | 3.8x |
| Irene Shin | SR CORPORATE COUNSEL | $239K | $239K | 2017–2017 | 3.2x |
| Hillary Nelson | SR DIRECTOR-CLINICAL DEVELOPMENT | $207K | $207K | 2017–2017 | 2.8x |
| Nadine Defranoux | PROGRAM MANAGER-TRANSLATIONAL SCIENCE | $207K | $207K | 2017–2017 | 2.8x |
| Susanne Hildebrand-Zanki | DIrector-special projects | $201K | $201K | 2016–2016 | 2.7x |
| Leticia Licea | HR & OFFICE MANAGER | $168K | $168K | 2016–2016 | 2.2x |
| Ehud Gold | EXECUTIVE DIRECTOR-TECHNOLOGY | $153K | $153K | 2016–2016 | 2x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 13 | $398K | $999K | $5.2M |
| 2017 | 15 | $389K | $911K | $5.8M |
| 2018 | 8 | $547K | $917K | $4.4M |
| 2019 | 8 | $528K | $910K | $4.2M |
| 2020 | 9 | $490K | $874K | $4.4M |
| 2021 | 10 | $517K | $791K | $5.2M |
| 2023 | 8 | $634K | $844K | $5.1M |
Email Alerts
Get notified about PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.